Depreciation, Depletion and Amortization of Neumora Therapeutics, Inc. from 31 Dec 2022 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary: Neumora Therapeutics, Inc. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
Neumora Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $157,000, a 0.63% decline year-over-year.
Neumora Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2024 was $631,000, a 5.5% decline from 2023.
Neumora Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $668,000, a 12% increase from 2022.
Source SEC data: View on sec.gov

Depreciation, Depletion and Amortization, Quarterly (USD)

Depreciation, Depletion and Amortization, YoY Quarterly Change (%)

Depreciation, Depletion and Amortization, Annual (USD)

Depreciation, Depletion and Amortization, YoY Annual Change (%)

Neumora Therapeutics, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$157,000	-$1,000	-0.63%	01 Jan 2025	31 Mar 2025	10-Q	12 May 2025	2025	Q1
Q1 2024	$158,000	$0	0%	01 Jan 2024	31 Mar 2024	10-Q	12 May 2025	2025	Q1
Q1 2023	$158,000			01 Jan 2023	31 Mar 2023	10-Q	07 May 2024	2024	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$631,000	-$37,000	-5.5%	01 Jan 2024	31 Dec 2024	10-K	03 Mar 2025	2024	FY
2023	$668,000	+$74,000	+12%	01 Jan 2023	31 Dec 2023	10-K	03 Mar 2025	2024	FY
2022	$594,000			01 Jan 2022	31 Dec 2022	10-K	03 Mar 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.